Forte Biosciences, Inc. Common Stock
€18.42
EUR
Last updated on --.
24h volume126.37K
24h highest19.8379 EUR
24h lowest18.4019 EUR
24h Price movement-2.32%
FBRX recent prices
24 Hours
-2.32%-€0.43855
30 days
-15.77%-€3.578
60 days
-15.56%-€3.522
90 days
-26.46%-€6.875
Key data
Previous close18.8662 EUR
Market cap357.65M EUR
Volume126.37K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.1816 EUR
Net income (FY)-65.23M EUR
Revenue (FY)--
Last report date11 May 2026
About Forte Biosciences, Inc. Common Stock
HeadquartersDALLAS
Employees (FY)22.00
Net income per employee (FY)-2.96M EUR
Listed onNasdaq
FBRX conversion tables
 |  |
|---|---|
| 0.5 FBRX | 9.213 EUR |
| 1 FBRX | 18.42 EUR |
| 5 FBRX | 92.13 EUR |
| 10 FBRX | 184.27 EUR |
| |
|---|---|
| 0.5 EUR | 0.027133 FBRX |
| 1 EUR | 0.054266 FBRX |
| 5 EUR | 0.27133 FBRX |
| 10 EUR | 0.54266 FBRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
FBRX is trading at €18.42, -2.32% over the last 24 hours. Track live moves on the price chart at the top of this page.
The FBRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. FBRX is currently trading at €18.42, -2.32% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on FBRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. FBRX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from FBRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against FBRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Forte Biosciences, Inc. Common Stock's market cap is currently 357.65M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume126.37K
24h highest19.8379 EUR
24h lowest18.4019 EUR
24h Price movement-2.32%
Start trade with FBRX Perpetual
Sign up to trade